Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Lozano

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|February 8, 2002
Tranexamic acid in hereditary hemorrhagic telangiectasiaMiguel Lozano
Medicina Clinica|November 8, 2002
[Severe non-infectious secondary effects of blood transfusion]Miguel Lozano Molero
Medicina Clinica|March 31, 2007
[Activated partial thromboplastin time]Miguel Lozano, Roberto Mazzara
Lancet (London, England)|May 28, 2003
Importance of languageMiguel Lozano, Roberto Mazzara
Transfusion|August 5, 2005
Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trialsJoan Cid, Miguel Lozano
Transfusion|February 27, 2007
Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trialsJoan Cid, Miguel Lozano
F1000Prime Reports|January 13, 2015
Transfusion medicine as of 2014Miguel Lozano, Joan Cid
Presse Medicale (Paris, France : 1983)|August 1, 2016
Platelet concentrates: Balancing between efficacy and safety?Miguel Lozano, Joan Cid
Transfusion Medicine Reviews|January 11, 2003
The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibilityMiguel Lozano, Joan Cid
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Quality indicators for Transfusion Medicine in Spain: a survey among hospital transfusion servicesIñigo Romon, Miguel Lozano
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|February 8, 2002
Tranexamic acid in hereditary hemorrhagic telangiectasiaMiguel Lozano
Medicina Clinica|November 8, 2002
[Severe non-infectious secondary effects of blood transfusion]Miguel Lozano Molero
Medicina Clinica|March 31, 2007
[Activated partial thromboplastin time]Miguel Lozano, Roberto Mazzara
Lancet (London, England)|May 28, 2003
Importance of languageMiguel Lozano, Roberto Mazzara
Transfusion|August 5, 2005
Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trialsJoan Cid, Miguel Lozano
Transfusion|February 27, 2007
Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trialsJoan Cid, Miguel Lozano
F1000Prime Reports|January 13, 2015
Transfusion medicine as of 2014Miguel Lozano, Joan Cid
Presse Medicale (Paris, France : 1983)|August 1, 2016
Platelet concentrates: Balancing between efficacy and safety?Miguel Lozano, Joan Cid
Transfusion Medicine Reviews|January 11, 2003
The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibilityMiguel Lozano, Joan Cid
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Quality indicators for Transfusion Medicine in Spain: a survey among hospital transfusion servicesIñigo Romon, Miguel Lozano
Pageof 12